Bo Jin

Title: **Innovations in Biotechnology: The Contributions of Inventor Bo Jin**

Introduction

Bo Jin, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of biotechnology. With a total of two patents to his name, he has demonstrated a strong commitment to advancing genetic engineering and polypeptide preparation. His innovative work is not only contributing to scientific knowledge but also holds potential for practical applications in the pharmaceutical industry.

Latest Patents

Bo Jin's latest patents are noteworthy advancements in biotechnology. The first patent focuses on a fusion protein and its preparation method for the intermediate polypeptide of Semaglutide. This invention involves a fusion protein that includes a fusion peptide, a protease cleavage site, and a target main molecular sequence. Optimizations in the fusion peptide sequence have led to an impressive increase in the expression levels of the fusion protein to 13.1 g/L. Additionally, enhancements in the properties of the fusion protein improve the subsequent extraction, enzyme digestion, and purification processes, making it more efficient for large-scale production.

The second patent unveils a low molecular weight chondroitin sulfate, which is produced using a process of lyase degradation and purification methods. This innovative product has an average molecular weight of less than 1000 Dalton and showcases a narrow molecular weight distribution. With a significant content of oligosaccharides and low protein levels, this low molecular weight chondroitin sulfate is effective in treating joint injuries and serves as a crucial ingredient for various medical, healthcare, and cosmetic products.

Career Highlights

Bo Jin is currently employed at Nanjing Hanxin Pharmaceutical Technology Co., Ltd., where he is dedicated to researching and developing new biotechnological solutions. His work in this company positions him at the forefront of pharmaceutical innovations and enables him to collaborate with other experts in the field.

Collaborations

Throughout his career, Bo Jin has worked alongside talented colleagues such as Haoning Zhang and Song Chen. Their collaborative efforts have contributed to the success of significant projects and patents, enhancing the research environment at Nanjing Hanxin Pharmaceutical Technology Co., Ltd. This teamwork not only fosters creativity but also leads to groundbreaking advancements in biotechnology.

Conclusion

In summary, Bo Jin's contributions to the field of biotechnology through his patents emphasize his innovative spirit and commitment to scientific research. His work on Semaglutide's intermediate polypeptide and low molecular weight chondroitin sulfate showcases the promising potential of his inventions in healthcare and industry. As he continues to collaborate with talented professionals in his field, the future of biotechnology holds great promise, driven by inventors like Bo Jin.